ENDO PHARMACEUTICALS HOLDINGS INC
 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): February 25, 2003 (February 25, 2003)

ENDO PHARMACEUTICALS HOLDINGS INC.


(Exact name of registrant as specified in its charter)
             
DELAWARE     39040     13-4022871

(State or other
jurisdiction of
incorporation)
    (Commission File Number)     (I.R.S. Employer
Identification No.)


           
100 Painters Drive
Chadds Ford, Pennsylvania
         
19317

(Address of principal executive offices)           (Zip Code)

(610) 558-9800


(Registrant’s telephone number, including area code)

N/A


(Former name or former address, if changed since last report)

 


 

Item 7. Financial Statements and Exhibits.

 
(a) Financial Statements of Business Acquired
 
          Not applicable
 
(b) Pro Forma Financial Information
 
          Not applicable
 
(c) Exhibits
     
Exhibit Number   Description

 
99.1   Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated February 25, 2003

Item 9. Regulation FD Disclosure.

     On February 25, 2003, the Registrant intends to make a slide presentation to investors at its offices in Chadds Ford, Pennsylvania, a copy of which presentation is filed herewith as Exhibit 99.1 and is incorporated herein by reference.

 


 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

             
    ENDO PHARMACEUTICALS HOLDINGS INC.
                        (Registrant)    

           
    By:   /s/ CAROL A. AMMON    
       
   
        Name: Carol A. Ammon    
        Title: Chairman & Chief Executive Officer    
Dated: February 25, 2003            

 


 

INDEX TO EXHIBITS

     
Exhibit No.   Description

 
99.1   Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated February 25, 2003